E-Mail
IMAGE: From left to right, CNIO researchers Belén Herráez, Anna González-Neira, Rosario Alonso, Nuria Álvarez, Ana Osorio, Rocío Núñez, Guillermo Pita, and Javier Benítez. view more
Credit: A. Garrido, CNIO
Genetic inheritance affects the likelihood of developing breast cancer. Some genes are already known to increase cancer risk; other genes are suspected to be involved, but not to what extent. It is crucial to clarify this issue to improve prevention since it opens the way to more personalised follow-up and screening programs. A large international consortium, which includes the Spanish National Cancer Research Centre (CNIO), has studied 34 putative susceptibility genes on samples from 113,000 female breast cancer cases and controls, and its results confirm the importance of nine of them.
Китай готов помогать странам Африки
rg.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rg.ru Daily Mail and Mail on Sunday newspapers.
В Польше призвали привозить детей в школы только на личном транспорте
regnum.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from regnum.ru Daily Mail and Mail on Sunday newspapers.
Study finds association between severity of COVID-19 and shorter telomeres
Patients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) in collaboration with the COVID-IFEMA Field Hospital, published in the journal
Aging.
The study, led by Maria A. Blasco and whose first authors are Raúl Sánchez and Ana Guío-Carrión, postulates that telomere shortening as a consequence of the viral infection impedes tissue regeneration and that this is why a significant number of patients suffer prolonged sequelae.
Blasco was already developing a therapy to regenerate lung tissue in pulmonary fibrosis patients; she now believes that this treatment -which should still take at least a year and a half to become available- could also help those who have lung lesions remaining after overcoming COVID-19.